Highlights
About
Stent System Technology for Preventing Embolization
InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention. Proprietary MicroNet mesh addresses the primary shortcomings and harmful consequences of conventional Carotid stenting and surgery.
InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for sustained embolic protection, neurovascular protection and stroke prevention. InspireMD is focused on changing the carotid/neurovascular market through expanding its portfolio of solutions along with pursuing applications of its MicroNet technology in other indications such as peripheral artery procedures.
Identity
| Name | InspireMD |
|---|---|
| Slug | inspiremd |
| Type / kind | startup |
| Crunchbase ID | inspiremd-inc |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6ZsZsKDA |
Status
| Status | active |
|---|---|
| Status reason | Public on NYSE on Apr 2011; |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Menorat HaMa'or Street 4, Tel Aviv, Israel |
Web & social
Classifications
Funding
| Total raised | $229.5M |
|---|---|
| Current stage | Public |
| Market cap | $75.4M |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}